Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06626633 | 2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML | suspended | Phase 1 | 6 | University of Maryland, BaltimoreOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT06219174 | Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO) | suspended | Phase 1 / Phase 2 | 45 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT06281925 | Cryotherapy & Oxaliplatin | suspended | N/A | 40 | NYU Langone HealthOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT06860386 | Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC | suspended | Phase 2 | 75 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT06235281 | Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)(PLIGHT) | suspended | Early Phase 1 | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT03467386 | Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia | suspended | Phase 1 | 56 | City of Hope Medical CenterOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT03065062 | Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors | suspended | Phase 1 | 75 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT05928806 | Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial(ARCITECT) | suspended | Phase 2 | 120 | Michael B. Atkins, MDOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT06213298 | Effect of Kava on Anxiety and Stress in Cancer Survivors | suspended | Early Phase 1 | 43 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT05428852 | Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases | suspended | N/A | 24 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT03875144 | Treatment of Malignant Peritoneal Mesothelioma (MESOTIP)(MESOTIP) | suspended | Phase 2 | 66 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT05062889 | Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients(ERASE-CRC) | suspended | Phase 2 | 477 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT04309552 | Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma | suspended | Phase 1 | 8 | Weill Medical College of Cornell UniversityOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT07353229 | 68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma | suspended | Phase 1 | 24 | Thomas Jefferson UniversityOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT06508034 | Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving Immunotherapy | suspended | N/A | 12 | Mayo ClinicOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06575686 | Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma | suspended | Phase 2 | 33 | City of Hope Medical CenterOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06355908 | IL13Rα2 CAR-T for Patients With r/r Glioma(ENHANCING) | suspended | Phase 1 | 30 | Yang ZhangOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT04855253 | Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL | suspended | Phase 1 / Phase 2 | 30 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT03500081 | Solid Tumor Imaging MR-Linac (STIM Study) | suspended | — | 295 | Medical College of WisconsinOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT05351294 | Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet | suspended | Phase 3 | 156 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT06649682 | 68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC(NYCRRLT) | suspended | Phase 1 | 20 | Peking Union Medical College HospitalOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT04840472 | Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer | suspended | Phase 1 | 28 | Stanford UniversityOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT05241210 | Real-Time Feedback (RTFB) to Improve Colonoscopy | suspended | N/A | 4,150 | University of MinnesotaOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT07268092 | Porcine Extracellular Matrix Nerve Wrap in Neck Dissection for Head and Neck Cancer | suspended | N/A | 74 | Henry Ford Health SystemOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT05358704 | Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer | suspended | Phase 2 | 38 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05064111 | Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy | suspended | — | 100 | University of ArizonaOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT04392050 | A Community-Based Educational Intervention to Improve Colorectal Cancer Screening | suspended | — | 90 | Thomas Jefferson UniversityOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT06709131 | A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia(CT0991) | suspended | Phase 1 | 24 | He HuangOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05844306 | RefleXion PET/CT Imaging Performance in Patients With Various Malignancies | suspended | N/A | 20 | City of Hope Medical CenterOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT05938296 | oHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection | suspended | Phase 1 | 29 | Binhui Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 19, 2025 | clinicaltrials |
| NCT06454409 | Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia | suspended | Phase 1 | 20 | City of Hope Medical CenterOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07178665 | Pilot Trial of Preop Partial Radiation in Breast Cancer Patients | suspended | Phase 1 | 98 | Rutgers, The State University of New JerseyOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT04657146 | Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma(LAMB-G) | suspended | — | 40 | Duke UniversityOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT06855628 | Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM) | suspended | Phase 2 | 10 | Stanford UniversityOTHER | 1 | Oct 28, 2025 | clinicaltrials |
| NCT05033522 | Immunotherapy for Advanced Liver Cancer(ALIVE) | suspended | Phase 2 / Phase 3 | 150 | Mirror Biologics, Inc.INDUSTRY | 2 | Oct 23, 2025 | clinicaltrials |
| NCT06940570 | Methadone as an Alternative Treatment for Children Underdoing HSCT(MATCH) | suspended | Phase 3 | 60 | University of Texas Southwestern Medical CenterOTHER | 1 | Oct 23, 2025 | clinicaltrials |
| NCT03392064 | A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC | suspended | Phase 1 | 6 | AmgenINDUSTRY | 1 | Oct 15, 2025 | clinicaltrials |
| NCT03417921 | A Study of ABTL0812 in Pancreatic Cancer(Pancreatic) | suspended | Phase 1 / Phase 2 | 60 | Ability Pharmaceuticals SLINDUSTRY | 1 | Oct 1, 2025 | clinicaltrials |
| NCT04300335 | The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma | suspended | N/A | 45 | Medical University of ViennaOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT03738267 | Study on the Occurrence of Head and Neck Cancers During Pregnancy(REFCORbirth) | suspended | — | 14 | Centre Francois BaclesseOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT04693546 | Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for CRC Screening(PREVENT) | suspended | — | 12,000 | Metabiomics CorpINDUSTRY | 1 | Sep 26, 2025 | clinicaltrials |
| NCT05445609 | Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer | suspended | Phase 2 | 10 | Emory UniversityOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT02742883 | A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG) | suspended | Phase 2 | 1 | Burzynski Research InstituteOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT05820633 | Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.(PCS-XI) | suspended | N/A | 500 | CHU de Quebec-Universite LavalOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT04418167 | JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations | suspended | Phase 1 | 71 | JS InnoPharm, LLCINDUSTRY | 1 | Sep 3, 2025 | clinicaltrials |
| NCT06639958 | A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home | suspended | N/A | 64 | Children's Oncology GroupNETWORK | 1 | Aug 29, 2025 | clinicaltrials |
| NCT05591534 | Endorectal Brachytherapy for Rectal Cancer(ICUREC) | suspended | Phase 2 | 31 | University Hospital, BordeauxOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT05055518 | APL-102 Capsule in Patients With Advanced Solid Tumors | suspended | Phase 1 | 30 | Apollomics Inc.INDUSTRY | 1 | Jun 27, 2025 | clinicaltrials |
| NCT05958199 | A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7 | suspended | Phase 1 | 131 | NextPoint Therapeutics, Inc.INDUSTRY | 1 | Jun 27, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Mar 12, 2026source: clinicaltrials